:: Healthcare BizDev ::

Brittany Tedesco

Senior Account Executive

CPR Strategic Communications

Office Location:

Elmwood Park, NJ USA

Company Information:

475 Market Street, 2nd Floor

Elmwood Park, NJ 07407 USA

201-641-1911

800-752-5588

HCBD Company Profile:
CPR Strategic Communications

Company Website:
http://cpronline.com

In The News

Sun Life and Virtual Me Partner to Expand Telehealth Services to Include Health Navigation

Great Speech and American TelePhysicians Announce Collaborative Partnership to Provide Virtual Speech Therapy Services to People of All Ages

aequum LLC Names Brandon Heusey as National Director of Sales

Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners, Advancing Innovative Virtual-First Care Service

View all remaining In The Stories headlines

Recuro Health is Featured Partner with Microsoft, Showcases Digital Medical Home

Recuro Health Appoints Managed Care and Healthcare Data Expert Josh Nordtvedt as Senior Vice President, Payer Strategy

Great Speech Announces Partnership with Health Network One: Provides Access to Virtual Speech Therapy Services for Members, Expands Payer's Specialty Network Management Solutions

Great Speech Announces Partnership with Centivo, Expands Access to Virtual Speech Therapy for Self-Funded Employer Health Plans

SYNAPS Dx DISCERN Provides First-to-Market Definitive Diagnostic Test for Alzheimer’s Disease, Supports Payer Treatment Decisions, Releases Paper Authored by Advisory Council

aequum Reveals 2022 Outlook for Employer Sponsored Health Plans: Strategies and Cost-Containment Opportunities to Minimize Risk and Optimize Value

CBS News "Global Thought Leaders" Series Features Echosens: Video Showcases FibroScan as Medical Gold Standard

Echosens Appoints Medical Equipment Expert Jo Massoels as Chief Marketing Officer, Expands Global Marketing of FibroScan to Halt Liver Disease Epidemic

Echosens Ranks Among PM360’s Leading Innovative Companies for 9th Annual Innovations Issue, Demonstrates Ingenuity During COVID-19 Pandemic

Echosens Partners with Gastrologix to Provide Independent GI Practices with FibroScan for Non-Invasive, Cost-effective Liver Health Examinations

Echosens Launches Collaborative Relationship With Healthy Trucking of America: Improves Liver Health, Safety and Productivity of Nation’s Professional Drivers

Echosens Announces Acceptance of Actuarial Study in American Journal of Managed Care: Positive Return on Investment of VCTE/CAP FibroScan Technology to Measure Liver Fat and Stiffness

Echosens Highlights Link Between Diabetes and Liver Disease, Urges Non-Invasive Detection and Monitoring of Liver Fat to Halt Disease Progression

Echosens Introduces FibroScan 630 Expert: Adds New Spleen Stiffness Measurement

Echosens Supports October 2020 Liver Cancer Awareness Month: Cites Link to Nonalcoholic Fatty Liver Disease and Importance of Early Detection

Echosen: Boost Workforce Productivity, Reduce Medical Costs: Integrate Echosens’ FibroScan Into MetaPhy’s Chronic Care Liver Disease Management Program

Echosens Emphasizes Critical Need to Monitor Liver Health, Identify Those Living with Silent Disease and Provide Follow-Up for Hepatitis C Virus

Echosens Announces NICE, UK Health Technology Assessment Organization, Issues MedTech Innovation Briefing on FibroScan Liver Exam in Primary Care

Integrating Echosens’ FibroScan into MetaPhy’s Chronic Care Liver Disease Management Program Impacts Patient Outcomes, Costs, Financial Performance of Gastroenterology Practices

Echosens and NASHNET Recognize International NASH Day, June 12, 2020: Collaboration, Best Practices and Early Detection of Fatty Liver Disease

Battle Fatty Liver Disease and Obesity, Inform Cost-Effective Treatment Decisions: Echosens Articulates Value of Non-Invasive Diagnostic Tool, FibroScan

Echosens: CDC Calls for Universal Hepatitis C Screening to Halt Advanced Liver Disease & Liver Cancer

Echosens Engages Santa Barbara Actuaries to Demonstrate Cost-effectiveness of FibroScan Non-invasive Technology for Measuring Liver Fat and Stiffness, Answers Payer Needs to Address NAFLD and NASH Epidemic

Study Validating Echosens FibroScan FAST Score for Cost-Effective, Efficient Identification of People at Risk for Active Fibrotic NASH Published in Lancet Gastroenterology & Hepatology

Echosens Aligns with Fatty Liver Foundation to Accelerate Screening for Undiagnosed Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Echosens Calls for Increased Vigilance by Healthcare Providers to Monitor Liver Health at Point of Care, Address Obesity, Diabetes and Halt Progression of NAFLD

Echosens at VA’s National Veterans Small Business Engagement Meeting: Demonstrating FibroScan Benefits for Early Detection and Monitoring of Liver Disease

Echosens FAST Score Revolutionizes the Assessment of NASH: Cost-Effective, Efficient Identification of Individuals at Risk for Active Fibrotic NASH

Echosens Supports October 2019 Liver Cancer Awareness Month: Cites Importance of Early Detection of Nonalcoholic Fatty Liver Disease

Echosens Releases White Paper: Addressing Risk for Cirrhosis, Liver Failure and Liver Cancer Among America’s Veterans

Echosens Appoints Dominique Legros as Group CEO: Global Healthcare Business and Technology Expert Leads Company Growth in Chronic Liver Disease Assessment

Eradicating Hepatitis C and Fatty Liver Disease: VA Broadens Contract with Echosens to Include FibroScan 430 Portable Technology, Expands Access to Screening and Early Detection

Carisk Selects Uber Health to Provide Reliable, Cost-Effective Transportation Solution in Workers’ Compensation: Improves Access, Lowers Cost of Care for Injured Workers

Concordia Care, Inc. Reveals New Corporate Identity: Carisk Partners Provides Specialty Risk Transfer and Quality Care Coordination for Complex Catastrophic Cases

Professional Affiliations

Senior Account Executive

CPR Strategic Communications

PR Agency Representative

Carisk Partners

HCBD-PRO Services

Query News -